What is the Medicare GLP-1 Bridge, and do you qualify?
The Medicare GLP-1 Bridge is a temporary Medicare program that covers Wegovy, Foundayo and the Zepbound KwikPen for weight management at a $50 monthly copay, from July 1, 2026 through December 31, 2027. You need Medicare drug coverage, a BMI that meets the program's thresholds (some also need a related health condition), and a prior authorization from your prescriber.
Reviewed by Darshan Patel, MD, Obesity medicine physician, on 2026-11-12. Next review 2027-02-12.
Book my consultation Video consultations with an obesity medicine physician. Most major insurance accepted, plus convenient cash pay options.
If you have Medicare and you've wondered whether it will help pay for a GLP-1, there's now a path for people who meet the criteria. Since July 1, 2026, a temporary program called the Medicare GLP-1 Bridge has covered certain GLP-1 medicines for weight management. Here's how it works, who qualifies and how to get it.
How the Bridge works
- $50 a month. You pay a $50 copay at the pharmacy for each one-month supply, which is 28 or 30 days depending on the medicine.
- Separate from your usual drug plan. CMS runs the Bridge outside your regular Part D benefit. The $50 doesn't count toward your Part D deductible or your yearly out-of-pocket cap, and Extra Help can't lower it.
- One month at a time. Each fill is a single 28- or 30-day supply. 60- and 90-day fills aren't available.
- For a limited time. Coverage runs from July 1, 2026 through December 31, 2027.
Which medicines it covers
| Medicine | Covered by the Bridge? |
|---|---|
| Wegovy (semaglutide) | Yes, the pill or the injection |
| Foundayo (orforglipron) | Yes, the pill |
| Zepbound (tirzepatide) | The KwikPen. Single-dose vials and single-dose pens aren't covered. |
Pen needles aren't covered.
Who qualifies
You need to be 18 or older, have Medicare drug coverage, and meet one of these when you start GLP-1 treatment:
- a BMI of 35 or higher
- a BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or higher
- a BMI of 27 or higher with prediabetes, a previous heart attack, a previous stroke, or peripheral artery disease with symptoms
Your prescriber also certifies that you're using the medicine as part of a lifestyle program focused on diet and exercise.
Your drug coverage can come from a stand-alone Part D plan or a Medicare Advantage plan with drug coverage (HMO, HMO-POS or PPO), including Special Needs Plans, employer or union group plans and the LI NET program.
The Bridge isn't the route for you if you already get a GLP-1 through your Part D plan, or if you have type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease. Your Part D plan may cover a GLP-1 for those conditions instead.
How to get it, step by step
- See a prescriber. They review your history and BMI and check which pathway you meet. CMS says a prescriber doesn't need to be enrolled in Medicare to write the prescription.
- The prescription goes to your pharmacy first. The pharmacy runs the claim, then sends the prior authorization request to your prescriber, usually within 24 to 72 hours. Pharmacies don't need to sign up separately for the Bridge.
- Your prescriber completes the prior authorization, electronically or by fax, and attests that you meet the criteria.
- You get a letter confirming your medicine is covered, then pay $50 at the pharmacy each month. The approval lasts through December 31, 2027, unless you switch to a different GLP-1.
There's no formal appeal. If something was entered wrong or your information changes, your prescriber can resubmit. For questions about eligibility or a prior authorization, call 1-800-MEDICARE (1-800-633-4227; TTY 1-877-486-2048).
After December 2027
CMS extended the Bridge through December 31, 2027 because its longer-term model for these medicines, called BALANCE, isn't launching in Medicare in 2027. CMS describes BALANCE in Part D only as a possible next step, so what comes after 2027 isn't settled yet. We'll update this page when CMS says more.
If you don't qualify
You still have choices. The makers sell Wegovy, Zepbound and Foundayo at cash prices (see GLP-1 cash prices), but read the terms before you pay: some offers, and the copay savings cards meant for commercial insurance, exclude people with government coverage such as Medicare. Medicine is also only one part of a good plan. Nutrition, activity, sleep and the other conditions you live with all shape what works for you.
Talk it through with a physician
Working out whether you qualify shouldn't mean guessing. In a video consultation, an obesity medicine physician goes over your health history with you, explains which Bridge pathway, if any, fits, and builds a plan around your goals, with medicine when it's right for you. We check your coverage before your visit, so you know where you stand. Book my consultation
Good to know
- This page explains a Medicare program in plain language. Medicare.gov and 1-800-MEDICARE have the final word on your own eligibility.
- Program details can change. We last checked them on November 12, 2026, and review this page every three months.
- A GLP-1 isn't right for everyone. Your physician reviews your health history and decides with you.
Questions people ask
How much does the Medicare GLP-1 Bridge cost?
$50 a month for a one-month supply, paid at the pharmacy. It doesn't count toward your Part D deductible or your yearly out-of-pocket cap, and Extra Help can't lower it.
Does a Medicare Advantage plan count?
Yes, if it includes drug coverage. The Bridge also works with stand-alone Part D plans, Special Needs Plans, employer or union group plans, and the LI NET program.
Is Zepbound covered?
The Zepbound KwikPen is. Single-dose Zepbound vials and single-dose pens aren't, and pen needles aren't covered either.
I have type 2 diabetes. Can I use the Bridge?
No. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease go through their regular Part D plan, which may cover a GLP-1 for those conditions.
When does the Bridge end?
December 31, 2027. CMS describes its longer-term model for these medicines in Part D only as a possible next step, so what comes after 2027 isn't settled.
What if my prior authorization is turned down?
There's no formal appeal. Your prescriber can resubmit the request if something was entered wrong or your information has changed. For questions about your status, call 1-800-MEDICARE.
Wondering whether you qualify?
Book a video consultation with an obesity medicine physician. We'll go over your health history, the Bridge criteria and your options, and build a plan with you even if you don't qualify. We check your coverage before your visit.
Sources
- CMS: Medicare GLP-1 Bridge (page modified July 13, 2026)
- CMS: Medicare GLP-1 Bridge, information for providers (page modified August 6, 2026)
- CMS: Medicare GLP-1 Bridge, information for pharmacies (page modified August 17, 2026)
- Medicare.gov: Weight loss drugs
- CMS: BALANCE Model (page modified September 29, 2026)
- KFF Health News: A new Medicare option for weight loss drugs (May 6, 2026)
- TrumpRx: Wegovy pill offer and terms
- NovoCare: Price your Wegovy, savings offer terms
- LillyDirect: Zepbound self-pay and savings card terms
- LillyDirect: Foundayo self-pay and savings card terms
